Healthcare -
Biotechnology - NASDAQ - US
$ 1.68
-8.7 %
$ 125 M
Market Cap
-1.45
P/E
IKT - OPERATING INCOME
Operating Income IKT - Inhibikase Therapeutics, Inc.
-28.6 M
LAST VALUE
-25.58%
2 YEAR CAGR
-38.07%
5 YEAR CAGR
0.00%
10 YEAR CAGR